Matthew H.J. Kim, CEO of Vigilant Biosciences,  is shown with co-founder Dr. Elizabeth Franzmann. Vigilant is working on an early detection system for risk of oral cancer.  PATRICK FARRELL MIAMI HERALD STAFF